Gregory R. Friberg, EVP, Chief R&D Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 6,326 shares at $60.38 ($382K) on 2026-02-26, disclosed to the SEC on 2026-02-26.
Open-market sale of $382k BMRN by EVP, Chief R&D Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.